Steps taken after granting the Marketing Authorisation 
For procedures finalised after 1 June 2004 please refer to module 8B. 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
On  15  April  2002,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a change in pack size. The EMEA issued the Notification for this variation on 17 May 2002. 
On  15  April  2002,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
changes in the manufacture of the medicinal product. The EMEA issued the Notification for this 
variation on 17 May 2002. 
On  15  April  2002,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a  change  in  container  shape.  The  EMEA  issued  the  Notification  for  this  variation  on  17  May 
2002. 
On  15  April  2002,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a change in storage conditions. The EMEA issued the Notification for this variation on 17 May 
2002. 
On  30  August  2002,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a  withdrawal  of  the  manufacturing  authorisation  for  a  site  of  manufacture.  The  EMEA  issued 
the Notification for this variation on 1 October 2002. 
On  30  August  2002,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a  change  in  the  name  the  marketing  authorisation  holder  with  a  consequential  change  in  the 
name of manufacturer. The EMEA issued the Notification for this variation on 1 October 2002. 
On  4  March  2003,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a minor change in the manufacture of the medicinal product. The EMEA issued the Notification 
for this variation on 8 April 2003. 
On  12  May  2003,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a change in test procedures of the medicinal product. The EMEA issued the Notification for this 
variation on 16 June 2003. 
On  24  June  2003,  the  Marketing  Authorisation  Holder  submitted  a  Type  I  Variation  in 
accordance with Commission Regulation (EC) No. 542/95 as amended. The variation related to 
a change in container shape. The EMEA issued the Notification for this variation on 5 August 
2003. 
On 16 April 2003, the Marketing Authorisation Holder submitted an application for a Type II 
variation in  accordance with Art. 6  of Commission  Regulation (EC) No. 542/95, as amended. 
The Marketing Authorisation Holder applied for an extension of the therapeutic indication for 
first line therapy. The CPMP during its October 2003 plenary meeting considered the variation 
acceptable  and  issued  on  22  October  2003  a  positive  Opinion  on  the  Type  II  variation.  The 
corresponding Commission Decision was issued on 20 January 2004. 
On  24  October  2003,  the  Marketing  Authorisation  Holder  submitted  a  Type  IA  Variation  in 
accordance with Commission Regulation (EC) No. 1085/2003. The variation related to a change 
in any part of the packaging material not in contact with the finished product. The EMEA issued 
the Notification for this variation on 5 November 2003. 
1/2 
EMEA 2004 
 
 
 
 
• 
The  MAH  submitted  on  14  April  2004  a  request  to  introduce  changes  to  an  aspect  of  the 
Labelling  not  connected  to  the  SPC,  in  accordance  with  Article  61(3)  of  Council  Directive 
2001/83/EC, as amended. This change concerned a change to the outer carton. The notification 
letter from the EMEA informing the MAH that the changes proposed were acceptable was dated 
10 May 2004. 
2/2 
EMEA 2004 
 
 
 
 
